Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedCap ABOSTO:MCAP +2.87%81 Median PS Value is kr431.04 as of Jul. 17, 2026, which is 100% below its 10-year median of 2.49. GuruFocus rates OSTO:MCAP with a GF Score™ of 81/100 and a GF Value™ of kr556.75 (Fairly Valued). Among 336 Medical Devices & Instruments companies, MedCap AB ranks worse than 82.74% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. MedCap AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was kr144.592. MedCap AB's 10-Year median PS Ratio is 2.9811. Therefore, the Median PS Value for today is kr431.04.
As of today (2026-07-17), MedCap AB's share price is kr519.50. MedCap AB's Median PS Value is kr431.04. Therefore, MedCap AB's Price to Median PS Value for today is 1.21.
The historical rank and industry rank for MedCap AB's Median PS Value or its related term are showing as below:
OSTO:MCAP'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 1.04 Med: 2.49 Max: 5.94
Current: 1.21
During the past 13 years, the highest Price to Median PS Value of MedCap AB was 5.94. The lowest was 1.04. And the median was 2.49.
OSTO:MCAP's Price-to-Median-PS-Value is ranked worse than 82.74% of 336
companies
in the Medical Devices & Instruments industry
Industry Median: 0.71
vs OSTO:MCAP: 1.21
MedCap AB (OSTO:MCAP) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
MedCap AB's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
519.50
/
431.04
=
1.21
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedCap AB Median PS Value Related Terms
MedCap AB Median PS Value Historical Data
* Premium members only.
The historical data trend for MedCap AB's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:MCAP vs ABT, SYK, MDT: Median PS Value Comparison
For the Medical Devices subindustry, MedCap AB's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedCap AB Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, MedCap AB's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where MedCap AB's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 2.9811.
MedCap AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr144.592.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedCap AB (OSTO:MCAP) has a Median PS Value of kr431.04 as of Jul. 17, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on MedCap AB and its competitors. This is 17211% above median its historical median of 2.49. Over the past decade, MedCap AB's Median PS Value has ranged from 1.04 to 5.94. According to the industry distribution chart, MedCap AB ranks #278 out of 336 companies in the Medical Devices & Instruments industry, placing it in the top 82.7%.
Is MedCap AB's Median PS Value too high?
MedCap AB's current Median PS Value of kr431.04 is 17211% above median its 10-year median of 2.49. Over the past 10 years, this metric has ranged from a low of 1.04 to a high of 5.94. Based on the distribution chart, MedCap AB ranks #278 out of 336 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, MedCap AB has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MedCap AB's Median PS Value compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, MedCap AB ranks #278 out of 336 companies for Median PS Value. This places MedCap AB in the lower half of its industry. The industry median Median PS Value is 0.71. Historically, MedCap AB's own Median PS Value has ranged from 1.04 to 5.94 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.71, based on 336 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on MedCap AB and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedCap AB's current Median PS Value is kr431.04, which is 17211% above median its own 10-year median of 2.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedCap AB stock overvalued right now?
Based on GuruFocus' analysis, MedCap AB (OSTO:MCAP) is currently considered Fairly Valued. The stock's GF Value™ is kr556.75, compared to a current price of kr519.50 — trading 6.7% below its estimated fair value. The current Median PS Value is kr431.04, which is 17211% above median its 10-year median of 2.49. MedCap AB's overall GF Score™ is 81/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For MedCap AB (OSTO:MCAP), the current Median PS Value is kr431.04 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MedCap AB (OSTO:MCAP) Overvalued in 2026?
Based on GuruFocus' analysis, MedCap AB stock appears to be undervalued.
The current stock price of kr519.50 is trading 6.7% below its estimated GF Value™ of kr556.75.
GuruFocus considers MedCap AB to be Fairly Valued.
Key valuation signals for OSTO:MCAP:
Median PS Value: kr431.04 (17211% above median its 10-year median of 2.49)
GF Value™: kr556.75 vs. price of kr519.50 (6.7% below fair value)
No single metric tells the full story. See the OSTO:MCAP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MedCap AB acquires and develops profitable, market-leading niche companies in the Nordic life science industry. It is diversified into two business areas namely Medical technology and Specialist medicines. Medical Technology mainly develops and sells various medical technology products and services. Its Specialist medicines develop and sell medicines within the regulatory classes of registered, extemporaneous and licensed medicines.
81GF Score
Get the complete analysis for OSTO:MCAP
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:MCAP has been successfully added to your 
